Dimerix (ASX:DXB), an Australian biopharmaceutical company currently in the clinical-stage, saw its shares reach an impressive 9.7% high at A$0.068, their greatest intraday percentage gain since August 2.

The value of DXB stocks is noted to be at their highest point since September 21.

Dimerix recently received conditional approval by the U.S.

Food and Drug Administration for the commercial brand name Qytovra.

It is worth mentioning that this approval also involves their third phase in clinical trial for a drug candidate to combat focal segmental glomerulosclerosis, a form of kidney disease.

Regardless of recent achievements, the stock was down by 56.3% year-to-date when compared with a 0.43% growth in the benchmark S&P/ASX 200 index as of the last close.

Dimerix is an Australian biopharmaceutical company known for its work in the clinical-stage developing treatments for kidney disease.

Shares of Polynovo (ASX:PNV) increased as much as 12.3% to A$1.37, setting a course towards their strongest day since June 7, subject to maintaining the surge.

Polynovo, the medical devices manufacturing company, reported total sales of A$13.0 million for the first two months of FY24, reflecting a jump of 83.9% compared to the corresponding period last year.

Furthermore, the company posted sales of A$6.8 million for August, an impressive rise by 110.8%.

Tracking the performance, Polynovo shares have reached their highest point since September 18.

Despite the recent gains, Polynovo’s stock still reflects a decline of 39.6% for the year to date, considering the position at the last close.

Polynovo is a company that specializes in medical devices manufacturing.

E-commerce company RooLife Group (ASX:RLG) sees its shares surge by 13.3% to A$0.017, the highest it has been since March 6.

The increase comes after the firm announced that it had received orders valued at A$1.95 million ($1.3 million) from Shanghai No.1 Pharmaceuticals.

In the course of the day, the company recorded its most significant intraday percentage gain since September 15.

Approximately 6.4 million shares were exchanged at 6.6 times the 30-day average volume of 967,125 shares.

The firm’s stocks are currently trading above its 50-, 100-, and 200-day simple moving averages, which indicates a bullish sentiment.

Despite the current market situation, the company’s stocks have seen an increase of 50% this year, up to the last closing price.

RooLife Group (ASX:RLG) is an e-commerce firm that specialises in developing and delivering digital marketing and customer acquisition strategies.

Costa Group (ASX:CGC), has seen a price target increase of A$3.20/share from A$3.10/share by analysts at Bell Potter, maintaining their ‘hold’ rating on the stock.

This Australian horticulture firm approved a purchase offer by a consortium headed by U.S.

private-equity firm Paine Schwartz Partners last Friday, a deal which evaluates the company at A$1.50 billion ($963.60 million).

Currently, Costa Group (ASX:CGC) shares are up by 0.7%.

The brokerage has highlighted that the offer’s 43% premium compared to the company’s share price after the initial offer in October eliminates the risk of a possible ‘overhang’ if the proposal had been rejected.

Among 10 analysts, four rate the stock as ‘buy’ or higher and six maintain a ‘hold’ stance.

Their median price target stands at A$3.10 based on LSEG data.

Costa Group (ASX:CGC) is an Australian horticulture company.

Shares of FOS Capital (ASX:FOS) have witnessed a significant increase of as much as 10%, reaching A$0.165.

This represents their highest level since late August.

The company, which provides lighting solutions, entered into a binding agreement for the acquisition of the Sydney-based linear lighting manufacturer, KLIK Systems.

The transaction amounted to A$3 million.

The acquisition is expected to increase FOS Capital’s market share in the linear lighting sector as well as streamline manufacturing operations for the company’s products.

The deal is slated for completion within a fortnight.

This has pushed the company’s stock to its biggest intraday jump since the beginning of September.

However, the stock of FOS Capital was down 21.1% for the year till the last closing.

FOS Capital is a company that provides innovative lighting solutions.

Australian developer Lendlease (ASX:LLC) has been advised by Morgan Stanley to offload its Communities business.

The advice from the brokerage is not born out of desire but necessity, as the unit’s divestiture is a requirement to keep Lendlease’s gearing ratio under control.

This comes as the company is planning to finance its development communities in the fiscal years 2024 and 2025.

Concurrently, Lendlease has seen its shares decline by as much as 1.4%.

Morgan Stanley is maintaining its price target at A$9.20 per share, keeping an ‘equal-weight’ rating for the company.

Earlier, media reports had circulated about discussions on the possible sale of the Communities business by Lendlease.

This was as CEO Tony Lombardo had intensified his five-year strategy to grow the construction colossus into an investment-led firm.

Morgan Stanley also posits that approximately A$1 billion in proceeds from the unit’s divestiture would significantly increase the balance sheet’s capacity.

The brokerage adds that the corporation requires these funds to support its share of development capital expenditure for the fiscal years 2024 and 2025.

Lendlease is a multinational construction company headquartered in Sydney, Australia.

Specializing in project management and construction services, its operations extend across Australia, Asia, Europe and the Americas.

Shares of Australian cannabis company Melodiol Global Health (ASX:ME1) surged as much as 20% to A$0.0060.

The company reports that its Canadian wing received three new purchase orders worth A$740,022.

There was further good news, as the unit had its highest sales week in Nova Scotia, Canada, taking place between September 11 and September 17.

These results come in contrast to the declining performance of the stock which noted a 75% drop Year-to-Date (YTD) at the last close, despite a 0.43% increase in the benchmark S&P/ASX 200 index.

Melodiol Global Health is a firm specializing in the cultivation and sale of medical cannabis.

According to analysts at Morgan Stanley, the halt in operations at a Rio Tinto (ASX:RIO) mining site in Pilbara is expected to have a negligible effect on production.

Rio Tinto (ASX:RIO), the world’s largest iron ore miner, paused its work after a scrub tree and a square meter rock fell from an overhang of a rock shelter near the site.

At this time, the company’s shares are trading down by 0.6% at A$113.9.

On Friday, the company announced the pause in operations after the geological incident.

Morgan Stanley adds that while the pit that was affected by the incident has been moved offsite, the medium-term impact will depend on the future of that pit.

Despite these circumstances, the brokerage maintains its ‘attractive’ rating and its price target of A$135 per share for Rio shares.

Among 14 analysts, nine rate the stock as ‘buy’ or higher, four recommend ‘hold’, and one advises to ‘sell’, with a median price target of A$122 according to LSEG data.

Rio Tinto (ASX:RIO) is the world’s largest iron ore miner known for its commitment to sustainable mining practices.

In the stock market, Intra Energy experienced a notable surge, with shares rising as much as 20% to A$0.006, on course for their best day since mid-September, assuming gains persist.

The uptick comes in response to the mineral explorer entering a binding agreement to procure 100% ownership of a dozen mineral claims adjacent to the company’s existing Llama Lithium project in Quebec, Canada.

These new claims were acquired from the Canadian Mining House, a noteworthy move that will expand the total ground coverage of the Llama Lithium Project to 75km2.

The acquisition necessitated a cash payment of C$120,000 and the issuance of 40 million fully paid ordinary shares in Intra Energy.

Despite this recent growth, Intra Energy’s value is still down 37.5% YTD from the previous close.

Intra Energy is a mining company specializing in the exploration and production of a variety of minerals.

Australian Mines (ASX:AUZ) recently announced Andrew Luke Nesbitt as their new CEO.

Nesbitt’s appointment will be effective from October 2.

He takes over the role from departing CEO Michael Holmes.

Australian Mines is a mining company focused on the exploration and development of high-grade cobalt, nickel and scandium projects.